These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8486343)
1. The treatment of low grade non-Hodgkin's lymphoma in elderly people. Rohatiner A; Johnson P; Norton A; Matthews J; Lister T Hematol Oncol; 1993; 11 Suppl 1():62-6. PubMed ID: 8486343 [No Abstract] [Full Text] [Related]
2. Isolated conjunctival lymphoma metastasis from previous low grade non-Hodgkin's lymphoma. Cackett P; Bower M; Stebbing J Postgrad Med J; 2005 Mar; 81(953):e1. PubMed ID: 15749786 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [TBL] [Abstract][Full Text] [Related]
4. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors of invasive non-Hodgkin's lymphoma]. Yu H; Hong XN; Li J; Peng LP; Ye L Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284 [TBL] [Abstract][Full Text] [Related]
7. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382 [TBL] [Abstract][Full Text] [Related]
8. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067 [TBL] [Abstract][Full Text] [Related]
9. [Primary extranodal non-Hodgkin's lymphoma of the head and neck]. Festini G; Longaro F; Volpe C Recenti Prog Med; 1997 Apr; 88(4):169-72. PubMed ID: 9206813 [TBL] [Abstract][Full Text] [Related]
10. [CEOP regimen in the treatment for non-Hodgkin's lymphoma]. Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140 [TBL] [Abstract][Full Text] [Related]
11. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202 [TBL] [Abstract][Full Text] [Related]
12. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx]. Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649 [TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma]. Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023 [TBL] [Abstract][Full Text] [Related]
14. Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. Leonard JP; Coleman M; Ketas JC; Chadburn A; Furman R; Schuster MW; Feldman EJ; Ashe M; Schuster SJ; Wegener WA; Hansen HJ; Ziccardi H; Eschenberg M; Gayko U; Fields SZ; Cesano A; Goldenberg DM Clin Cancer Res; 2004 Aug; 10(16):5327-34. PubMed ID: 15328168 [TBL] [Abstract][Full Text] [Related]
15. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277 [TBL] [Abstract][Full Text] [Related]
16. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
17. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Ahmed S; Kussick SJ; Siddiqui AK; Bhuiya TA; Khan A; Sarewitz S; Steinberg H; Sison CP; Rai KR Eur J Cancer; 2004 Jun; 40(9):1320-6. PubMed ID: 15177490 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma. Shvidel L; Klepfish A; Berrebi A Am J Hematol; 2001 Jul; 67(3):213-4. PubMed ID: 11391724 [No Abstract] [Full Text] [Related]
19. [Prognostic factors in low-grade lymphoma]. Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223 [TBL] [Abstract][Full Text] [Related]
20. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil]. Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]